4//SEC Filing
Attie Kenneth 4
Accession 0001209191-09-005345
CIK 0001340744other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 4:20 PM ET
Size
9.2 KB
Accession
0001209191-09-005345
Insider Transaction Report
Form 4
Attie Kenneth
VP, Clinical Dev & Med Affairs
Transactions
- Award
Common Stock Option (right to buy)
2009-01-27+250,000→ 250,000 totalExercise: $0.22Exp: 2019-01-27→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]All of such options have a term of ten years vesting over four years, with 1/16th of the options vesting every three months. All of such options become exercisable as they vest.
Issuer
Altus Pharmaceuticals Inc.
CIK 0001340744
Entity typeother
Related Parties
1- filerCIK 0001454829
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 4:20 PM ET
- Size
- 9.2 KB